QMS Medical Allied Services Ltd
Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices[1]
- Market Cap ₹ 313 Cr.
- Current Price ₹ 162
- High / Low ₹ 165 / 69.0
- Stock P/E 29.1
- Book Value ₹ 53.9
- Dividend Yield 0.31 %
- ROCE 13.2 %
- ROE 10.4 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 3.00 times its book value
- Company has a low return on equity of 12.0% over last 3 years.
- Promoter holding has decreased over last 3 years: -5.56%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|
| 122 | 156 | 173 | 183 | |
| 104 | 130 | 146 | 155 | |
| Operating Profit | 18 | 25 | 27 | 28 |
| OPM % | 15% | 16% | 15% | 15% |
| 0 | 2 | 1 | 1 | |
| Interest | 3 | 5 | 7 | 7 |
| Depreciation | 3 | 4 | 5 | 5 |
| Profit before tax | 12 | 19 | 16 | 17 |
| Tax % | 26% | 27% | 28% | |
| 9 | 14 | 12 | 13 | |
| EPS in Rs | 4.66 | 6.26 | 5.21 | 5.56 |
| Dividend Payout % | 0% | 0% | 10% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 4% |
| 1 Year: | 81% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 12% |
| Last Year: | 10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 18 | 18 | 19 |
| Reserves | 61 | 72 | 85 |
| 35 | 60 | 68 | |
| 22 | 40 | 41 | |
| Total Liabilities | 135 | 190 | 213 |
| 24 | 53 | 57 | |
| CWIP | 2 | 3 | 0 |
| Investments | 2 | 3 | 5 |
| 108 | 131 | 150 | |
| Total Assets | 135 | 190 | 213 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 1 | 20 | 19 | |
| -3 | -45 | -20 | |
| 0 | 26 | 1 | |
| Net Cash Flow | -1 | 1 | 0 |
| Free Cash Flow | 1 | 20 | 19 |
| CFO/OP | 26% | 101% | 91% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 124 | 101 | 142 |
| Inventory Days | 172 | 176 | 181 |
| Days Payable | 90 | 76 | 73 |
| Cash Conversion Cycle | 205 | 202 | 250 |
| Working Capital Days | 148 | 100 | 105 |
| ROCE % | 17% | 13% |
Insights
In beta| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Institutional Clients (Pharma Companies) Clients |
|
||
| Number of B2B Health Camps Conducted Camps |
|||
| Number of Product SKUs SKUs |
|||
| Number of Trained DMLT Field Technicians DMLTs |
|||
| Patients Served (Screened / On Digital Platform) Patients |
|||
| Serviceable PIN Codes PIN codes |
|||
| Total Employees / Professionals Employees |
|||
Extracted by Screener AI
Documents
Announcements
-
General Updates
- Sent web-link to FY2025-26 annual report and 9th AGM notice to shareholders without registered emails.
-
Record Date
- Book closed Sept 24-30, 2026 for 9th AGM and potential dividend; record date Sept 23, 2026.
-
Updates
- 9th AGM on Sept 30, 2026; annual report issued, Rs0.50 dividend record date Sept 23, 2026.
-
Shareholders meeting
- 9th AGM on September 30, 2026; 5% final dividend, director reappointment, and ₹20 crore related party transactions.
-
Outcome of Board Meeting
- Board appointed Pranav Badheka as independent director; approved material related party transaction and 9th AGM notice.
Annual reports
Concalls
-
Aug 2026Transcript PPT REC
-
Aug 2026TranscriptAI SummaryPPT
-
Jun 2026TranscriptPPT
-
Feb 2026TranscriptAI SummaryPPT
-
Nov 2025Transcript PPT
-
Aug 2025TranscriptPPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
Business Overview:[1]
QMASL does marketing and distribution of medical products and medical education services to clinics, pharma, medical companies and also to individual users. These devices are sold directly in the brand of the manufacturer and are sold under the brand name Q Devices. Company manages the distribution for other brands viz. 3M, Heine, Rossmax, etc.